Tralokinumab (Anti-IL-13)
Product Specifications
CAS Number
1044515-88-9
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Tralokinumab (Anti-IL-13) is a fully human IgG4 monoclonal antibody specifically targeting IL-13 with high affinity. It can be used for the research of the atopic dermatitis (AD) . MW :145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470225-100 1x 100 µL
Major Vault Protein (MVP) (1032), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040907-500 1x 500 µL
TTF-1 / NKX2.1 (8G7G3/1 + NX2.1/690), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB1820-500 1x 500 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), 0.2mg/mL
Sign In for Pricing
View Details